Form 4: Precision BioSciences CFO John Alexander Kelly Reports Stock Transactions
SEC Form 4 Filing
John Alexander Kelly, CFO of Precision BioSciences, reports the acquisition and disposal of common stock and restricted stock units.
Summary
- John Alexander Kelly, the Chief Financial Officer of Precision BioSciences, filed a Form 4 with the SEC.
- The report details transactions involving the company's common stock and restricted stock units (RSUs).
- On February 29, 2024, Kelly acquired 506 shares of common stock at a price of $18.5 per share.
- On May 1, 2024, 1,702 RSUs vested and were settled, resulting in the acquisition of 1,702 shares of common stock.
- Following these transactions, Kelly directly owns 22,680 shares of Precision BioSciences common stock and 1,702 RSUs.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions by a company executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors for signals about management's confidence in the company's prospects.
Stakeholder Impact
- Shareholders may be interested in the trading activity of company insiders as an indicator of management's view of the company's value.
Key Dates
| Date | Description |
|---|---|
| 03/03/2022 | Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 3, 2023. |
| 03/03/2023 | First vesting date of RSUs granted on March 3, 2022. |
| 02/13/2024 | Precision Biosciences effected a 1-for-30 reverse stock split. |
| 02/29/2024 | Acquisition of 506 shares of common stock at $18.5 per share. |
| 03/03/2024 | Partial vesting of Restricted Stock Units. |
| 05/01/2024 | Settlement of vested RSUs, resulting in the acquisition of 1,702 shares. |
| 05/03/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.